Replimune director Pucci proposes $2.83M share sale
Replimune Group, Inc. (REPL) Director Paolo Pucci reported a proposed sale of 138,700 common shares, with an aggregate market value of $2,833,987.75 and an approximate sale date of November 3, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Replimune Group, Inc. (REPL) Director Paolo Pucci reported a proposed sale of 138,700 common shares, with an aggregate market value of $2,833,987.75 and an approximate sale date of November 3, 2026. Morgan Stanley Smith Barney LLC is listed as the broker. The shares are listed as acquired from the issuer through a stock option exercise, with cash payment, on November 3, 2026.
Key Figures
Key Terms
Rule 144 regulatory
Stock Option Exercise technical
Aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.